Debate over Glowing Plants Grows

A Kickstarter project that promises donors Arabidopsis seeds transfected with firefly genes is causing a stir.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Arabidopsis thaliana, the plant that the Glowing Plant Project seeks to light upWIKIMEDIA, SUI-SETZThe Glowing Plant Project, which has raised more than $450,000 from nearly 8,000 backers on the crowd-funding website www.kickstarter.com, promises to send donors seeds, for laboratory workhorse Arabidopsis thaliana and roses, that are engineered to carry firefly genes that will cause the plants to emit a faint blue-green glow. But the project is sowing more than glowing plant seeds. It’s reigniting a debate over responsible uses of synthetic biology and the release of genetically modified organisms into the environment.

Objections to genetic modification typically emerge over the topic of GM crop plants or livestock. But the Glowing Plant Project has raised concerns from anti-GM activists and industry watchdogs alike. The ETC Group, an environmental organization that opposes all GM organisms, has even tried to launch its own campaign to stop the Kickstarter project.

“We are extremely concerned that the USDA is not planning to regulate the first-ever field release of an organism engineered through synthetic biology technologies. . . . We urge the USDA to put a halt to this risky, unregulated pursuit,” the groups wrote in a letter to the US Department of Agriculture in April.

In fact, the Silicone Valley entrepreneurs behind the Glowing Plant Project have satisfied the USDA’s existing regulations ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies